Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year.
Retro Biosciences正在筹集10亿美元，以资助这家利用人工智能(AI)的生物技术公司实现延长人类寿命十年的使命——从今年启动其首款药物的试验开始。
您已阅读5%（283字），剩余95%（5542字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。